Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literature

Pasteurella multocida infection is most commonly associated with the immunocompromised, mostly in the form of soft-tissue infection, although other sites of infection are still possible and have been reported in the immunocompetent. We report a case of an immunocompetent male with a history of expos...

Full description

Bibliographic Details
Main Authors: Stella Pak, Damian Valencia, Jenna Decker, Victor Valencia, Yusuf Askaroglu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Lung India
Subjects:
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=3;spage=237;epage=240;aulast=Pak
id doaj-b87f31049620474cbd7a0a936aa3d32d
record_format Article
spelling doaj-b87f31049620474cbd7a0a936aa3d32d2020-11-25T00:21:01ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2018-01-0135323724010.4103/lungindia.lungindia_482_17Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literatureStella PakDamian ValenciaJenna DeckerVictor ValenciaYusuf AskarogluPasteurella multocida infection is most commonly associated with the immunocompromised, mostly in the form of soft-tissue infection, although other sites of infection are still possible and have been reported in the immunocompetent. We report a case of an immunocompetent male with a history of exposure to carrier organisms without portal of entry who developed P. multocida pneumonia with bacteremia. We undertook a focused review of literature of previously reported cases of P. multocida pneumonia in patients with chronic obstructive pulmonary disease. This literature review supports the use of penicillins as the first line of treatment over macrolides. Considering the high mortality rates with P. multocida bacteremia, it is important for clinicians to maintain a high level of suspicion for this organism in any patient with a history of carrier species exposure.http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=3;spage=237;epage=240;aulast=PakChronic obstructive pulmonary diseasecommunity-acquired pneumoniaPasteurella multocida
collection DOAJ
language English
format Article
sources DOAJ
author Stella Pak
Damian Valencia
Jenna Decker
Victor Valencia
Yusuf Askaroglu
spellingShingle Stella Pak
Damian Valencia
Jenna Decker
Victor Valencia
Yusuf Askaroglu
Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literature
Lung India
Chronic obstructive pulmonary disease
community-acquired pneumonia
Pasteurella multocida
author_facet Stella Pak
Damian Valencia
Jenna Decker
Victor Valencia
Yusuf Askaroglu
author_sort Stella Pak
title Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literature
title_short Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literature
title_full Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literature
title_fullStr Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literature
title_full_unstemmed Pasteurella multocida pneumonia in an immunocompetent patient: Case report and systematic review of literature
title_sort pasteurella multocida pneumonia in an immunocompetent patient: case report and systematic review of literature
publisher Wolters Kluwer Medknow Publications
series Lung India
issn 0970-2113
0974-598X
publishDate 2018-01-01
description Pasteurella multocida infection is most commonly associated with the immunocompromised, mostly in the form of soft-tissue infection, although other sites of infection are still possible and have been reported in the immunocompetent. We report a case of an immunocompetent male with a history of exposure to carrier organisms without portal of entry who developed P. multocida pneumonia with bacteremia. We undertook a focused review of literature of previously reported cases of P. multocida pneumonia in patients with chronic obstructive pulmonary disease. This literature review supports the use of penicillins as the first line of treatment over macrolides. Considering the high mortality rates with P. multocida bacteremia, it is important for clinicians to maintain a high level of suspicion for this organism in any patient with a history of carrier species exposure.
topic Chronic obstructive pulmonary disease
community-acquired pneumonia
Pasteurella multocida
url http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=3;spage=237;epage=240;aulast=Pak
work_keys_str_mv AT stellapak pasteurellamultocidapneumoniainanimmunocompetentpatientcasereportandsystematicreviewofliterature
AT damianvalencia pasteurellamultocidapneumoniainanimmunocompetentpatientcasereportandsystematicreviewofliterature
AT jennadecker pasteurellamultocidapneumoniainanimmunocompetentpatientcasereportandsystematicreviewofliterature
AT victorvalencia pasteurellamultocidapneumoniainanimmunocompetentpatientcasereportandsystematicreviewofliterature
AT yusufaskaroglu pasteurellamultocidapneumoniainanimmunocompetentpatientcasereportandsystematicreviewofliterature
_version_ 1725364353661665280